This certified CME/CE enduring video archive is designed to educate healthcare providers treating or wishing to treat persons with HIV and/or AIDS, hepatitis, and/or HIV/hepatitis coinfection on the clinical application of the latest scientific data to achieve improved patient outcomes. There are no prerequisites.
Release Date: April 3, 2018
Expiration Date: April 2, 2019
Healthcare providers who treat or wish to treat persons with HIV and/or AIDS, hepatitis, and/or HIV/hepatitis coinfection.
After participating in this activity, participants should demonstrate the ability to:
METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME/CE information.
- Review all modules associated with this course.
- Successfully complete the post-test (70% accuracy).
- Complete the CME/CE evaluation.
- The estimated time to complete this activity is 10.5 hours.
- Upon successful completion, your CME/CNE certificate will be available to print for your records. CPE credit will be submitted to Duquesne University and posted to CPE Monitor.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME/CE activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine, the Association of Nurses in AIDS Care (ANAC) and the Duquesne University School of Pharmacy. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ANAC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Duquesne University School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
CREDIT DESIGNATION STATEMENTS
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Association of Nurses in AIDS Care (ANAC) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This enduring activity is approved for 10.5 contact hours by the Association of Nurses in AIDS Care.
This knowledge-based activity is accredited for 10.5 hours of continuing pharmacy education (CPE) credit. Duquesne University School of Pharmacy will report all credit to CPE Monitor within 60 working days after receiving evidence of successful completion of the course. Successful completion includes achieving a score of at least 70% on the test and a completed evaluation.
Duquesne University School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (UAN # ). All pharmacists are required to provide their NABP e-Profile ID # and Date of Birth (in MMDD format) for issuance of CE credits for any ACPE-accredited CPE sessions. Please go to the following website for full details: https://nabp.pharmacy/cpe-monitor-service/
Participation in the entire knowledge-based activity is required to obtain a certificate. This activity is being presented without bias and with commercial support.
POLICY ON SPEAKER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the instructional materials.
FULL DISCLOSURE POLICY AFFECTING CME/CE ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:
Joseph Eron, MD
Consulting Fee – AbbVie; Bristol-Myers Squibb; Gilead Sciences; Merck and Company, Inc.; Roche; Tibotec/Janssen; Trio and Viiv Healthcare
Data Safety Monitoring Board – TaiMed
Research Grant (Principal Investigator) – AbbVie; Bristol-Myers Squibb; Gilead Sciences; Janssen; and ViiV Healthcare
Charles W. Flexner, MD
Consulting Fee – Merck and Company, Inc. and Mylan Pharmaceuticals
Rajesh T. Gandhi, MD
Consulting Fee – EMD Serono and Theratechnologies
Educational grant support (Activity Director) – Gilead Sciences; Janssen; Merck and Company, Inc.; and Viiv Healthcare
Jeanne Marrazzo, MD, MPH, FACP, FIDSA
Consulting Fee – Biofire Diagnostics
Data Safety Monitoring Board – Gilead Sciences
Kenneth H. Mayer, MD
Research Grant (Principal Investigator) – Gilead Sciences
Michael Mugavero, MD
Consulting Fee – Gilead Sciences
Susanna Naggie, MD, MHS
Lecture Fee – Clinical Care Option; IAS-USA; Mentor Meetings; Platform Q Health; Practice Point Communications; and Vindico
Research Grant (Principal Investigator) – AbbVie; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck and Company, Inc.; and Tacere
Marion G. Peters, MD
Salary (spouse) – Hoffman La Roche
Michael S. Saag, MD
Consulting Fee – Bristol-Myers Squibb; Gilead Sciences; and Merck and Company, Inc.
Research Grant (Principal Investigator) – Bristol-Myers Squibb; Gilead Sciences; Merck and Company, Inc.; and Viiv Healthcare
Kenneth E. Sherman, MD, PhD
Consulting Fee – Abbott Laboratories, Inc. and Merck, Sharp and Dohme
Data Safety Monitoring Board – MedPace and Watermark
Research Grant (Principal Investigator) – AbbVie; Bristol-Myers Squibb; Gilead Sciences; Inovio; and Intercept
Mark S. Sulkowski, MD
Consulting Fee – AbbVie and Gilead Sciences
Research Grant (Principal Investigator) – AbbVie; Allergan; Gilead Sciences; and Merck and Company, Inc.
Stacey Trooskin, MD, PhD
Research Grant (Principal Investigator) – Gilead Sciences
No other individual in a position to control the content of this activity has indicated that they have any financial interests or relationships with a commercial entity.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Grants to investigators at the Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
OPINIONS AND OFF-LABEL DISCUSSIONS
In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.
CONFIDENTIALITY DISCLAIMER FOR CME/CE ACTIVITY PARTICIPANTS
I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am participating in this capacity, I may be exposed to “protected health information,” as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person’s health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g., Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.
The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.
For CME Questions, please contact the CME Office (410) 502-9634 or e-mail email@example.com. For CME Certificates, please call (410) 502-9634.
Johns Hopkins University School of Medicine, Office of Continuing Medical Education, Turner 20/720 Rutland Avenue, Baltimore, Maryland 21205-2195. Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/03) (Updated 4/09 and 3/14)
2018©All rights reserved - The Johns Hopkins University School of Medicine.
Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:
The Materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without prior written permission.
To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit https://hopkinscme.cloud-cme.com.
- Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
- Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution.
- Network: An Internet connection with 1Mbps available download & 256kbps bandwidth.
- Windows XP or above running Internet Explorer 7 (service pack 2) or above.
- MAC OSX 10.5 (Leopard) or above running Safari 5.1 or above, or any version of Chrome, Firefox or Opera published in the last two years.
- A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above.
- Any Apple iPad or iPad Mini running iOS 5 or above.
- Most high-performance Android tablets such as the Kindle Fire or Samsung Galaxy S.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by independent educational grants from AbbVie, Gilead Sciences Medical Affairs, Janssen Therapeutics (Division of Janssen Products, LP), Merck & Co., Inc., Theratechnologies, and ViiV Healthcare.